1. Xu, Jiaxuan, Dong, Xiaoqing, Wang, Ruoyi, Chen, Bing. 2022. DOK2 Has Prognostic and Immunologic Significance in Adults With Acute Myeloid Leukemia: A Novel Immune-Related Therapeutic Target. In Frontiers in medicine, 9, 842383. doi:10.3389/fmed.2022.842383. https://pubmed.ncbi.nlm.nih.gov/35321466/
2. Chen, Ming, Zhang, Jiangwen, Berger, Alice H, Plevin, Robin, Pandolfi, Pier Paolo. 2018. Compound haploinsufficiency of Dok2 and Dusp4 promotes lung tumorigenesis. In The Journal of clinical investigation, 129, 215-222. doi:10.1172/JCI99699. https://pubmed.ncbi.nlm.nih.gov/30475228/
3. Berger, Alice H, Chen, Ming, Morotti, Alessandro, Varmus, Harold E, Pandolfi, Pier Paolo. 2013. DOK2 inhibits EGFR-mutated lung adenocarcinoma. In PloS one, 8, e79526. doi:10.1371/journal.pone.0079526. https://pubmed.ncbi.nlm.nih.gov/24255704/
4. Lyons, Anthony, Downer, Eric J, Costello, Derek A, Murphy, Niamh, Lynch, Marina A. 2012. Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia. In Journal of neuroinflammation, 9, 107. doi:10.1186/1742-2094-9-107. https://pubmed.ncbi.nlm.nih.gov/22642833/
5. Laletin, Vladimir, Bernard, Pierre-Louis, Montersino, Camille, Guittard, Geoffrey, Nunès, Jacques A. 2024. DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing. In Scientific reports, 14, 15053. doi:10.1038/s41598-024-66075-0. https://pubmed.ncbi.nlm.nih.gov/38956389/
6. Deshpande, Ravindra Pramod, Chandra Sekhar, Y B V K, Panigrahi, Manas, Babu, Phanithi Prakash. 2016. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma. In Molecular neurobiology, 55, 402-408. doi:10.1007/s12035-016-0324-2. https://pubmed.ncbi.nlm.nih.gov/27975172/
7. Miyagaki, Hiromichi, Yamasaki, Makoto, Takahashi, Tsuyoshi, Mori, Masaki, Doki, Yuichiro. 2011. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection. In Annals of surgical oncology, 19, 1560-7. doi:10.1245/s10434-011-2157-6. https://pubmed.ncbi.nlm.nih.gov/22130622/